SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solidify ties in the bioindustry, today announced the signing of a Memorandum of Understanding (MOU) focused on fostering collaboration among life science companies in South Korea and California.
“Biocom California has worked extensively to partner with international life science organizations, which provides opportunities for our members to collaborate with international innovators,” said Joe Panetta, president emeritus of Biocom California. “Our relationship with KoreaBIO has been especially fruitful over the last several years, resulting in numerous opportunities for life science industry innovators to establish beneficial business relationships and new members based in Korea like Samsung Biologics. We are pleased to advance this relationship today with the signing of this Memorandum of Understanding.”
The objective of the MOU is to promote cooperation and foster partnerships that will result in increased innovation, funding and market opportunities in South Korea and California. Associated activities will include providing access to platforms and programs designed to catalyze co-investment and co-development opportunities, cooperation in planning and encouraging joint attendance at relevant events produced by Biocom California or KoreaBIO, and efforts to bring biopharmaceutical and life science companies together in California and South Korea.
“This MOU is expected to significantly expand practical opportunities for exchange and collaboration between Korean and U.S. biotech companies,” said Dr. Seung-Kyou Lee, vice president of KoreaBIO. “We hope that this partnership will closely link the bio-innovation ecosystems of both countries and accelerate their entry into global markets.”
About Biocom California
Biocom California is the leader and advocate for California’s life science sector. We work on behalf of our members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.
For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook and X.
Contacts
Biocom California Media Contact:
Carolyn Hawley
Inizio Evoke Comms
(619) 849-5382
[email protected]
